Some readers suggested earlier this year that I look into a clinic firm called ‘Stem Cell Centers’ with its owner Travis Autor. I didn’t have time to do much since I’ve been very busy in the lab before the state Attorney Generals of Iowa and Nebraska sued them based on a number of allegations including […]
2 State AG’s sue ‘Stem Cell Centers’ clinics including for alleged fraud Read More »
The biotech Mesoblast is starting an expanded access study of its stem cell product for kids with a severe offshoot of COVID-19. The cellular drug in this case is remestemcel-L (more below). While most children fare better than adults in dealing with COVID-19, the rare subset of kids with COVID-19 for this study have more severe
New Mesoblast “COVID kid” stem cell study Read More »
What’s new in the stem cell, cell therapy, and regenerative medicine world as well as biomedical science more generally including cancer? There’s quite a bit of news as reflected in media pieces and new pubs. Today’s post is focused on pubs that just came out. For last week’s recommended reads see here. Oct4-Sox2 Nucleosome Binding
OCT4-SOX DNA dance, PRC2, a noisy competition & more cell weekly reads Read More »
Note that this is post “সস্য কোষ (স্টেম সেল) কাকে বলে?” in Bengali is one part of our “Stem Cells Not Lost in Translation” series. You can see the full series of our stem cell white paper in the other 34 languages here. সস্য কোষ (স্টেম সেল) কাকে বলে? মানবদেহে শত শত বিভিন্ন ধরণের কোষ
সস্য কোষ (স্টেম সেল) কাকে বলে? What are stem cells in Bengali Read More »
Why is former Texas Governor/Trump Energy Secretary Rick Perry plugging unproven stem cells from a clinic firm called Celltex for COVID-19 prevention on Fox News? Perry follows in Giuliani’s footsteps? And more generally, what is it with conservative politicians promoting unproven therapies for COVID-19 and in particular stem cells for the novel coronavirus disease? First,
Rick Perry plugs Celltex MSCs on Fox for COVID-19 prevention Read More »
Katie Thomas at the New York Times reports that BARDA has dropped considering funding applications for stem cells for COVID-19. The move is part of a larger shift in funding priorities away from lung treatments and toward vaccine development. The decision has puzzled and even angered some stem cell firms and researchers. BARDA stands for
BARDA drops funding of research into stem cells for COVID-19 Read More »
Today’s post lists the best stem cell blogs and more generally the top biology blogs as well as websites. Making lists of “the best” of anything is fun yet tricky. However, I feel that it can also serve a purpose as a resource. You might also enjoy these other “top” lists I’ve done including List of
20 best biology & stem cell blogs for 2021 Read More »
My weekly roundups of biomedical news tend to focus on stem cells, but I read more broadly so it’s not just stem cells but also CAR-T cells and a lot more this week. CAR-T cells as senolytics? A team led by Scott Lowe has a new intriguing paper in Nature on using CAR-T cells to
Weekly roundup: CAR-T cells, exosomes, trout cloning Read More »
One of the most common questions that patients have asked me over the last decade is, “how much does stem cell therapy cost?” They actually seem most often to want to know more specifically how much the treatments should cost. To try to authoritatively answer this we need data from the present and past along
How much does stem cell therapy cost in 2022? Read More »
My lab and I are fortunate that in our Sacramento-Davis area there are relatively few COVID-19 cases, but what kind of COVID-19 risk mitigation plan should one use for a careful lab ramp-up plan? COVID-19 shouldn’t be the “elephant in the lab”, but should be discussed openly. Communication is probably one key to optimal ramp-up.
Research lab ramp-up plan & real-world tips to lower COVID-19 risk Read More »